European Society for Medical Oncology (ESMO)

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 05 Dec 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

350,000€

Financial year: Jan 2016 - Dec 2016

Lobbyists (Full time equivalent)

1.5 Fte (3)

Lobbyists with EP accreditation

3

High-level Commission meetings

3

Lobbying Costs over the years

  • Info

    European Society for Medical Oncology   (ESMO)

    EU Transparency Register

    947929324977-41 First registered on 08 Dec 2016

    Goals / Remit

    ESMO is the leading professional organisation for medical oncology. We are the society of reference for oncology education and information, and are committed to supporting our members to develop and advance in a fast-evolving professional environment. Cancer patients and their needs are at the centre of all that we do: our profession is driven by our determination, individually and collectively, to secure the best possible outcomes for people with cancer across Europe and around the world.

    ESMO's mission is:
    -To improve the quality of prevention, diagnosis, treatment, supportive and palliative care, as well as the follow up of patients with malignant disorders.
    -To advance the art, science, recognition, and practice of oncology.
    -To disseminate knowledge in oncology to cancer patients and the public.
    -To educate and train persons involved in clinical cancer care and research.
    -To promote education in oncology in order to ensure a high standard of qualification of medical oncologists within the multidisciplinary team.
    -To facilitate equal access to optimal cancer care to all cancer patients.
    -To maintain liaisons with other oncology specialties, cancer leagues, universities, patient groups and, where appropriate, the pharmaceutical industry.

    Main EU files targeted

    EU policy fields of interest for ESMO include Health, Cancer, Chronic Diseases, Research and Innovation, Cross Border Health Care, Health Technology Assessment, Data Protection, and Clinical Trials.

    Address

    Head Office
    Via Luigi Taddei 4
    Viganello-Lugano 6962
    SWITZERLAND
    EU Office
    Square de Meeûs 37
    4th Floor
    Brussels 1000
    BELGIUM
  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    75%1
    50%1
    25%1

    Lobbyists (Full time equivalent)

    1.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    3 accreditations were / are live (in bold) for the selected state of 05 Dec 2017

    Name Start date End Date
    Ms Tanya KENNY 07 Mar 2024 06 Mar 2025
    Mr Paul James LAFFIN 22 Feb 2024 21 Feb 2025
    Ms Agata KUSIAK 17 Feb 2024 14 Feb 2025
    Mr Marijn Scholte 14 Dec 2023 13 Dec 2024
    Mr Robert Delis 18 Apr 2023 17 Apr 2024
    Mr Paul James LAFFIN 19 Oct 2022 19 Oct 2023
    Ms Daniela Morghenti 15 Oct 2022 14 Oct 2023
    Mr Marijn Scholte 06 Oct 2022 05 Oct 2023
    Ms Fiona GREENHALGH 20 Feb 2020 01 Mar 2021
    Ms Anna CARTA 07 Nov 2019 07 Nov 2020
    Ms Emilie Hoogland 12 Mar 2019 01 Apr 2020
    Ms Malvika Vyas 06 Mar 2019 29 Feb 2020
    Ms Anna CARTA 22 Sep 2018 01 Oct 2019
    Mr Paolo Casali 14 Apr 2018 13 Apr 2019
    Ms Malvika Vyas 02 Mar 2018 02 Mar 2019
    Ms MONICA GHEORGHE 31 Aug 2017 31 Aug 2018
    Ms Malvika Vyas 23 Jan 2017 19 Jan 2018
    Ms Aurélie Paviza 23 Jan 2017 31 Aug 2017
    Mr Paolo Casali 23 Jan 2017 19 Jan 2018

    Complementary Information

    None declared

    Person in charge of EU relations

    Ms Malvika Vyas (Head of Public Policy)

    Person with legal responsibility

    Mr Keith Hanson - McGregor (CEO)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Trade unions and professional associations

  • Networking

    Affiliation

    ESMO is a Founding Member of: European CanCer Organisation (ECCO), Rare Cancers Europe (RCE), European Chronic Disease Alliance (ECDA), European Alliance for Personalized Medicine (EAPM). ESMO is a Full Member of: Union of International Cancer Control (UICC, Geneva), European Medicines Agency (EMA) Healthcare Professionals Working Party, Association of the NCD Alliance. ESMO also takes part in the Stakeholder Pool of the European Commission Health Technology Assessment Network. ESMO has an Official Relations Status with the World Health Organisation (WHO).

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2016 - Dec 2016

    Lobbying costs for closed financial year

    350,000€

    Other financial info

    http://www.esmo.org/About-Us/How-We-Work/ESMO-Funding

  • EU Structures

    Groups (European Commission)

    European Commission's Expert Group on Cancer Control

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    3 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard